Mohammad Vahabi: Exploring the Role of JAK Inhibitors in Urticarial Vasculitis
Mohammad Vahabi, Research Fellow at Rush University Medical Center, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Cutaneous Medicine and Surgery, adding:
“Glad to see our systematic review on Janus kinase inhibitors for urticarial vasculitis published in the Journal of Cutaneous Medicine and Surgery.
We identified 20 reported patients treated with tofacitinib, upadacitinib, or ruxolitinib. All patients showed clinical improvement, with 50% achieving complete response and 50% partial response.
While these early findings are encouraging, larger controlled studies are needed to better define the role of JAK inhibition in refractory urticarial vasculitis.
Many thanks to my co-authors Sama Heidari, Elnaz Pourgholi, Dr. Michael Fein, Dr. Joe K. Tung, and Erin Xiaolu Barrett for their contributions and collaboration, and a special thank you to Elena Netchiporouk for her invaluable support and guidance throughout this work.”
Title: Janus Kinase Inhibitors for Urticarial Vasculitis: A Systematic Review of 20 Patients
Authors: Sama Heidari, Elnaz Pourgholi, Elena Netchiporouk, Michael Fein, Joe K. Tung, Erin X. Wei, Seyed Mohammad Vahabi
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 31, 2026, 19:50Agata Sobczynska-Malefora: How Age and Ethnicity Influence Active Vitamin B12 and MMA Levels
-
Oct 31, 2026, 19:47David Shoultz: Running for MPN Research at the ASH Annual Meeting
-
Oct 31, 2026, 19:40Andreas Calatzis: Revisiting a Widely Cited Study on Preoperative Screening for Primary Hemostasis Disorders
-
Oct 31, 2026, 19:40How Antiseizure Medication Selection May Influence DOAC Safety in Epilepsy – JAMA Neurology
-
Oct 31, 2026, 19:35Alejandro González Veliz: Balancing Ischemic Protection and Bleeding Risk in Antiplatelet Management
-
Oct 31, 2026, 19:29Sascha David: Therapeutic Plasma Exchange Associated with Lower 90 Day Mortality in Streptococcal Septic Shock
-
Oct 31, 2026, 19:25Jessica Garcia: Real-World Evidence on Efanesoctocog Alfa Prophylaxis in Pediatric Hemophilia A
-
Oct 31, 2026, 19:21Cedric Hermans: What If Higher Plasma FIX Levels Do Not Necessarily Mean better Haemostatic Protection?
-
Oct 31, 2026, 19:16Valance Washington: Celebrating Sravya Nimmala’s Outstanding Abstract Award